Navigation Links
Vermillion Announces CEO Succession Plan
Date:5/15/2012

face the challenges associated with ovarian cancer. The company has a solid foundation for the future, and I remain committed to the tasks at hand and the smooth transition to a new president and CEO. The company has a first-class management team in place, and I am grateful for their support and that of our customers and collaborators."

As part of the leadership succession plan, Page has resigned from the board of directors.

About OVA1

OVA1 is a blood test for pre-surgical assessment of ovarian tumors for malignancy, using a unique multi-biomarker approach. In a published clinical trial, OVA1 achieved 99% sensitivity in detecting epithelial ovarian cancers (EOC). This included 96% sensitivity for stage I EOC, the earliest and most curable EOC stage, compared with 57% for the conventional biomarker CA125.(1) In addition, OVA1 found 70% of malignancies missed by non-specialist pre-surgical assessment,(1) and it increased detection of malignancy over ACOG guidelines from 77% to 94%.(2) As the first protein-based, In Vitro Diagnostic Multi-Variate Index Assay (IVDMIA) cleared by the FDA, OVA1 also represents a new class of software-based diagnostics.

Citings:

1)     Ueland, FR, et al. Obstet Gynecol 2011:VOL 117, NO. 6, June 2011
2)     Miller R, et al. Obstet Gynecol 2011:VOL 117, NO. 6, June 2011

About Vermillion

Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Additional information about Vermillion can be found at www.vermillion.com.'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
2. Vermillion to Report Preliminary Results for Fourth Quarter and Fiscal Year 2011 on February 23, 2012
3. Vermillion Completes the Acquisition of Correlogic Systems Ovarian Cancer Diagnostics Business
4. Vermillion Reports Results for Third Quarter 2011
5. Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011
6. Vermillion Engages Liolios Group to Lead Investor Relations Program
7. Vermillion Enhances Management Team With A Key Addition
8. Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories
9. Vermillion Reports Financial Results for the First Quarter 2011
10. Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
11. Vermillion Attends 42nd Annual Meeting of the Society of Gynecologic Oncologists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... AARP Foundation today announced it has established a relief ... cold weather that has gripped much of the nation. AARP ... so to support these emergency relief efforts AARP and AARP ... mean up to $500,000 in aid. The matching program will ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... commitments from institutional investors to purchase an aggregate of ... an at-the-market registered direct offering, led by a dedicated ... definitive purchase agreements with these investors pursuant to which ...
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... 16, 2011 /PRNewswire-Asia-FirstCall/ -- China ... (Nasdaq: CMED ), ... diagnostic ("IVD") company, today announced ... at the following investor conferences ...
... artery disease (CAD), also known as coronary heart disease, ... affecting about 17 million Americans(1). Most of these people ... angina pectoris. For over 100 years, physicians have treated ... nitroglycerin(2). Considered the gold standard in treating acute angina, ...
Cached Medicine Technology:China Medical Technologies to Meet Investors 2Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray 2Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray 3Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray 4
(Date:7/9/2014)... injection drug users in Russia might contribute to ... study, conducted by researchers from Boston University Schools ... St. Petersburg Pavlov State University, sought to discover ... outcomes of a cohort of HIV-positive people with ... were arrested by police were more likely to ...
(Date:7/9/2014)... YORK (July 8, 2014) Researchers from Montefiore ... of Medicine of Yeshiva University will present new ... held July 12 July 17 in Copenhagen, Denmark. ... that could prompt transition from cognitive normality to mild ... the Einstein Aging Study , established in 1980 ...
(Date:7/9/2014)... important organs in the human body. Its job is ... this is its synthesis function and that toxic ... its detoxification function. Lack of exercise and too much ... The resulting diseased cells can lead to inflammations, cancerous ... to the German Liver Foundation, over five million people ...
(Date:7/9/2014)... July 9, 2014 A study published in the ... Koninck and Robert Bonin, two researchers at Universit Laval, ... using a new method that involves rekindling pain so ... lead to novel means to alleviate chronic pain. , ... Laval and Institut universitaire en sant mentale de Qubec ...
(Date:7/8/2014)... Department of Defense,s Defense Advanced Research Projects Agency ... to $2.5 million to develop an implantable neural ... neurons within the brain to help restore memory, ... builds on the understanding that memory is a ... the brain encode information, store it and retrieve ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Discovery of a new means to erase pain 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 2Health News:DARPA selects Lawrence Livermore to develop world's first neural device to restore memory 3
... Alliance Leverages the Adify Platform to Aggregate Leading ... Baby Boomers Caring for Aging Parents, SAN ... a comprehensive online resource for people caring,for aging ... ), the first vertical ad,network to reach baby ...
... 2008A team of Universit Laval researchers has shown that the ... brains of mice fed a diet rich in animal fat ... diets typical of most industrialized countries promote the development of ... of Aging . , To demonstrate this, the team led ...
... will add significant growth to the ... company,s first aid ... Bulletin Board: DSCI) announced today that it has secured two,additional ... the highly popular and growing segment of printed,bandages allows for ...
... Month, SANTA MONICA, Calif., Oct. 28 /PRNewswire/ - ... coined to express the benefits of keeping physically fit,but ... Numerous studies,have shown that regular brain training sessions -- ... help stave off dementia and even the,symptoms of Alzheimer,s ...
... study between leading researchers in academia and industry from US, Australian ... 293 cell growth and productivity using protein derived from colostrum. ... ... A recent breakthrough was published in the scientific journal In Vitro ...
... LeonardoMD is pleased to announce that Medical Reimbursement ... Web-based practice management software to automate their high-volume ... billing for several dozen providers using LeonardoMD over ... outcome. LeonardoMD takes pride in working with ...
Cached Medicine News:Health News:Caring.com Launches First Ad Network to Reach Family Caregivers 2Health News:A high-fat diet could promote the development of Alzheimer's 2Health News:Derma Sciences Announces 3-Year Licensing Deals for Highly Profitable Character Strip Bandages 2Health News:10 Surprising Facts About Using Brain Training to Fight Dementia 2Health News:10 Surprising Facts About Using Brain Training to Fight Dementia 3Health News:Global Scientific Research Collaboration Leads to Breakthrough in Culturing HEK 293 Cells in Animal-free Media 2Health News:Medical Reimbursement Consultants, Inc. Selects LeonardoMD for Web-based Medical Billing 2Health News:Medical Reimbursement Consultants, Inc. Selects LeonardoMD for Web-based Medical Billing 3
For use with cushioned neckband....
... PVC siliconized. Stainless steel spiral reinforced. X-ray ... use. Adjustable Flange: The flange can be ... the thickness of the cervical soft tissue. ... the flange is tightly connected to the ...
... The permanent flexible tube ... of the neck flange helps ... neck, chin, and stoma, enhancing ... ,Bivona® FlexTend™ tracheostomy tubes ...
Aire-Cuf® tracheostomy tubes are ideal for short-term to medium-term ventilator support....
Medicine Products: